Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00507K1034
Ticker AGN
Company ALLERGAN
Currency $
Price
Aware Investor Index (AII) 0.0001
Recommendation STRONG SELL
P/E 65.53
ROE 1.11 %
Capitalization 47,284,470,000 $
Dividend Yield 0.00 %
P/S 3.00
AII Position 707
P/E Position 646
ROE Position 719
Capitalization Position 191
Dividend Yield Position 594
Sales 15,787,400,000 $
10-Year Average Earnings 721,520,000 $
Shares Outstanding 337,000,000
Equity 65,131,000,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
ALLERGAN Investor Relations Web Site http://www.allergan.com/INVESTORS







Sales:

YEAR MONTH AMOUNT
2018 12 15,787,400,000.00 $
2017 12 15,940,700,000.00 $
2016 12 14,570,600,000.00 $
2015 12 15,071,000,000.00 $
2014 12 13,062,300,000.00 $
2013 12 8,677,600,000.00 $
2012 12 5,914,900,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -5,142,800,000.00 $
2017 12 -4,403,900,000.00 $
2016 12 14,695,000,000.00 $
2015 12 3,683,200,000.00 $
2014 12 -1,630,500,000.00 $
2013 12 -750,400,000.00 $
2012 12 97,300,000.00 $
2011 12 260,900,000.00 $
2010 12 184,400,000.00 $
2009 12 222,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 65,131,000,000.00 $
2017 12 73,837,100,000.00 $
2016 12 76,200,500,000.00 $
2015 12 76,589,300,000.00 $
2014 12 28,335,500,000.00 $
2013 12 9,537,100,000.00 $
2012 12 3,856,400,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 337,000,000
2017 12 333,800,000
2016 12 384,900,000
2015 12 367,800,000
2014 12 219,700,000
2013 12 142,300,000
2012 12 128,400,000

 









Comments:

DATE COMMENT
2014-04-19 13:06:45 Equity increased after Warner Chilcott acquisition



Bloomberg News for ALLERGAN:



Google News for ALLERGAN:

GV Times - 1 day ago
Allergan plc (AGN) Price Watch: Buyers Picking Up Steam!
It has been reported that multiple insider activity took place at Allergan plc (AGN). Chairman, President and CEO SAUNDERS BRENT L ...
Hermann Herald
The Price to Cash For Allergan plc ($AGN) Placed Under Scrutiny as ...
Allergan plc (AGN) has a Price to sales ratio of 2.954918. Investors may use Price to Book to display how the market portrays the value of a ...
Finance Daily
Hot Stocks Evaluation: Union Pacific Corporation (NYSE:UNP ...
Union Pacific Corporation (UNP) with the stream of 0.60% also noticed, India Allergan plc (AGN) encountered a rapid change of -0.04% in the ...
Glenwood Guardian
Nomura Holdings Cut Starbucks (Put) (SBUX) Holding; 7 Analysts ...
Among 12 analysts covering Allergan (NYSE:AGN), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Allergan had 28 analyst ...
Chandler Caller - 10 hours ago
Magic Formula Rank For Allergan plc ($AGN$) Placed Under ...
Allergan plc ($AGN$) has a current MF Rank of 3440. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot ...
Stocks Equity (press release) - 11 hours ago
Allergan: An Undervalued Pharma Company; Focusing On The ...
At Kays Financial, we recently added Allergan (AGN) to portfolios, which we view as an inexpensive stock offering an attractive risk/reward ...
The NBO News - 3 hours ago
Incredibly impressive Fundamentals: Allergan plc (AGN)
Allergan plc (NYSE:AGN) has had quite a remarkable price journey over the past year. During the past 12 months, its highest price was ...
Chandler Caller - 11 hours ago
Allergan plc (AGN): what caused a meltdown today?
An interesting stock that came up in some of our conversations today is Allergan plc (NYSE:AGN). At current price of $138.52, the shares have ...
Seeking Alpha - 26 Mar 2019
Will Allergan (AGN) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its nex t ...
Nasdaq
Why You Should Be Watching Revance Therapeutics
Allergan (AGN) originally received FDA approval for Botox type A in 2002, derived from botulinum toxin, made by the bacteria that causes ...


Back